The Merck biochemist found the compound that led to a popular cholesterol-lowering drug.

The cholesterol-lowering drugs could be used to treat people with two types of dwarfism, a study suggests.

Biochemistry reveals the missing link in a pathway that archaea and some bacteria use to generate essential compounds.

Studying and treating the chronic diseases associated with aging needs serious revamping.

A genetic variant may help explain why some patients experience muscle discomfort and dysfunction while taking the cholesterol-lowering medications.